Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study to Assess the Effect of Different Dosing Intervals on the Multiple-Dose Pharmacokinetics of WD-1603 (25mg Carbidopa/150mg Levodopa) When Administered Before Meals in Healthy Participants

NCT07442591 is registered in ClinicalTrials.gov with Shanghai WD Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT07442591
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07442591 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study to Assess the Effect of Different Dosing Intervals on the Multiple-Dose Pharmacokinetics of WD-1603 (25mg Carbidopa/150mg Levodopa) When Administered Before Meals in Healthy Participants
Lead sponsor
Shanghai WD Pharmaceutical Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
March 17, 2026
Completion date
April 23, 2026
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healhty